(Q77896050)
Statements
Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin (English)
G P Stathopoulos
S Rigatos
scientific article published on 01 July 1999
No description defined